DrugPatentWatch Database Preview
Details for Biologics License Application: 761108
» See Plans and Pricing
Summary for BLA: 761108
Tradename: | ULTOMIRIS |
Applicant: | Alexion Pharm |
Ingredient: | ravulizumab-cwvz |
Patents: | 7 |
Approval Date: | Oct 18, 2019 |
Suppliers: see list | 1 |
US Patents for BLA: 761108
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Alexion Pharm | ULTOMIRIS | ravulizumab-cwvz | INJECTABLE;INJECTION | 761108 | 001 | 2019-10-18 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2034-03-07 | RX | Orphan | company |
Alexion Pharm | ULTOMIRIS | ravulizumab-cwvz | INJECTABLE;INJECTION | 761108 | 001 | 2019-10-18 | Start Trial | ALEXION PHARMACEUTICALS, INC. (Cheshire, CT) | 2034-03-07 | RX | Orphan | company |
Alexion Pharm | ULTOMIRIS | ravulizumab-cwvz | INJECTABLE;INJECTION | 761108 | 001 | 2019-10-18 | Start Trial | Alexion Pharmaceuticals, Inc. (Cheshire, CT) | 2034-03-07 | RX | Orphan | company |
Alexion Pharm | ULTOMIRIS | ravulizumab-cwvz | INJECTABLE;INJECTION | 761108 | 001 | 2019-10-18 | Start Trial | Alexion Pharmaceuticals, Inc. (Cheshire, CT) | 2034-03-07 | RX | Orphan | company |
Alexion Pharm | ULTOMIRIS | ravulizumab-cwvz | INJECTABLE;INJECTION | 761108 | 001 | 2019-10-18 | Start Trial | Alexion Pharmaceuticals, Inc. (New Haven, CT) | 2034-03-07 | RX | Orphan | company |
Alexion Pharm | ULTOMIRIS | ravulizumab-cwvz | INJECTABLE;INJECTION | 761108 | 001 | 2019-10-18 | Start Trial | Alexion Pharmaceuticals, Inc. (New Haven, CT) | 2034-03-07 | RX | Orphan | company |
Alexion Pharm | ULTOMIRIS | ravulizumab-cwvz | INJECTABLE;INJECTION | 761108 | 001 | 2019-10-18 | Start Trial | Alexion Pharmaceuticals, Inc. (New Haven, CT) | 2034-03-07 | RX | Orphan | company |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |